61 related articles for article (PubMed ID: 30846677)
21. Muscular Metastasis of Hepatocellular Carcinoma: Case Report and Literature Review.
Nakayama A; Arai J; Otoyama Y; Sugiura I; Nakajima Y; Kajiwara A; Ichikawa Y; Uozumi S; Shimozuma Y; Uchikoshi M; Sakaki M; Tazawa S; Shiozawa E; Yamochi T; Takimoto M; Yoshida H
Intern Med; 2022 Jan; 61(2):189-196. PubMed ID: 34219106
[TBL] [Abstract][Full Text] [Related]
22. Solitary Metastasis of Hepatocellular Carcinoma to the Rectus Abdominis 13 Years After the Initial Treatment.
Kato R; Sakamoto A; Noguchi T; Matsuda S; Terajima H
ACG Case Rep J; 2021 May; 8(5):e00607. PubMed ID: 34036115
[TBL] [Abstract][Full Text] [Related]
23. Features of extrahepatic metastasis after radiofrequency ablation for hepatocellular carcinoma.
Yoon JH; Goo YJ; Lim CJ; Choi SK; Cho SB; Shin SS; Jun CH
World J Gastroenterol; 2020 Aug; 26(32):4833-4845. PubMed ID: 32921960
[TBL] [Abstract][Full Text] [Related]
24. Rare Site Hepatocellular Carcinoma Metastasis.
Boldo E; Santafe A; Mayol A; Lozoya R; Coret A; Escribano D; Fortea-Sanchis C; Muñoz A; Pastor JC; Perez de Lucia G; Bosch N
J Hepatocell Carcinoma; 2020; 7():39-44. PubMed ID: 32274362
[TBL] [Abstract][Full Text] [Related]
25. [Complete disappearance with oral UFT administration of recurrent hepatocellular carcinoma of the remnant liver and multiple lung metastasis after hepatic resection].
Matsushita A; Hanazaki K; Noike T; Nakagawa K; Misawa R; Nakata T; Nomura K; Kobayashi A; Miwa S; Miyagawa S; Kawasaki S
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1327-32. PubMed ID: 14518415
[TBL] [Abstract][Full Text] [Related]
26. Fibrolamellar hepatocellular carcinoma in a Japanese man: report of a case.
Yoshimi F; Asato Y; Amemiya R; Itabashi M; Nakamura K
Surg Today; 2002; 32(2):174-9. PubMed ID: 11998950
[TBL] [Abstract][Full Text] [Related]
27. Solitary Muscle Metastasis of Hepatocellular Carcinoma to the Biceps Femoris Muscle with Only Elevated Serum PIVKA-II: A Case Report.
Orita K; Sakamoto A; Okamoto T; Matsuda S
Am J Case Rep; 2019 Mar; 20():306-309. PubMed ID: 30846677
[TBL] [Abstract][Full Text] [Related]
28. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
Feng H; Li B; Li Z; Wei Q; Ren L
BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA.
Wu J; Xiang Z; Bai L; He L; Tan L; Hu M; Ren Y
Cancer Biomark; 2018; 23(2):235-242. PubMed ID: 30103302
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.
Seo SI; Kim HS; Kim WJ; Shin WG; Kim DJ; Kim KH; Jang MK; Lee JH; Kim JS; Kim HY; Kim DJ; Lee MS; Park CK
World J Gastroenterol; 2015 Apr; 21(13):3928-35. PubMed ID: 25852278
[TBL] [Abstract][Full Text] [Related]
31. Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients.
Viggiani V; Palombi S; Gennarini G; D'Ettorre G; De Vito C; Angeloni A; Frati L; Anastasi E
Scand J Gastroenterol; 2016 Oct; 51(10):1257-62. PubMed ID: 27227515
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma.
Park SJ; Jang JY; Jeong SW; Cho YK; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Park S; Bang HI
Medicine (Baltimore); 2017 Mar; 96(11):e5811. PubMed ID: 28296720
[TBL] [Abstract][Full Text] [Related]
33. Novel des-γ-carboxy prothrombin in serum for the diagnosis of hepatocellular carcinoma.
Tanaka T; Taniguchi T; Sannomiya K; Takenaka H; Tomonari T; Okamoto K; Kitamura S; Okahisa T; Tamaki K; Mikasa H; Suzuki S; Takayama T
J Gastroenterol Hepatol; 2013 Aug; 28(8):1348-55. PubMed ID: 23432345
[TBL] [Abstract][Full Text] [Related]
34. Solitary metastasis to the intercostal muscle from hepatocellular carcinoma: A case report.
Furumoto K; Miura K; Nagashima D; Kojima H; Mori T; Ito D; Kajimura K; Kogire M
Int J Surg Case Rep; 2012; 3(7):322-6. PubMed ID: 22554941
[TBL] [Abstract][Full Text] [Related]
35. Protein induced by vitamin K absence or antagonist-II production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma: a prospective evaluation.
Bae HM; Lee JH; Yoon JH; Kim YJ; Heo DS; Lee HS
BMC Cancer; 2011 Oct; 11():435. PubMed ID: 21985636
[TBL] [Abstract][Full Text] [Related]
36. Muscle metastasis from hepatocellular carcinoma.
Michalaki V; Zygogianni A; Kouloulias V; Balafouta M; Vlachodimitropoulos D; Gennatas CG
J Cancer Res Ther; 2011; 7(1):81-3. PubMed ID: 21546750
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
